The retrospective analysis of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer

被引：0
|
作者：
Ueno, M. [1 ]
Kobayashi, S. [1 ]
Ohkawa, S. [1 ]
Tezuka, S. [1 ]
Moriya, S. [1 ]
Morimoto, M. [1 ]
机构：
[1] Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Med Oncol, Yokohama, Kanagawa 2410815, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
224P
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [1] A Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer Refractory to Gemcitabine Monotherapy
    Nishioka, Mariko
    Okano, Naohiro
    Wakabayashi, Masashi
    Ikeno, Takashi
    Hayashi, Masato
    Mizutani, Tomonori
    Nagashima, Fumio
    Furuse, Junji
    [J]. ANTICANCER RESEARCH, 2024, 44 (03) : 1233 - 1239
  • [2] FOLFIRINOX for advanced pancreatic cancer patients after nab-paclitaxel plus gemcitabine failure: retrospective analysis
    Matsumoto, Toshihiko
    Kimura, Shogo
    Himei, Hitomi
    Okazaki, Ukyo
    Kurioka, Yusuke
    Tsuduki, Takao
    Takagi, Shijiro
    Takatani, Masahiro
    Hiramatsu, Ysushi
    Morishita, Hirofumi
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [3] Reinitiating nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Borazanci, Erkut
    Schroeder, Katy
    Jameson, Gayle S.
    Ramanathan, Ramesh K.
    Von Hoff, Daniel D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [4] A Multicenter Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Elderly Patients With Advanced Pancreatic Cancer
    Kobayashi, Satoshi
    Ueno, Makoto
    Ikeda, Masafumi
    Ozaka, Masato
    Sano, Yusuke
    Hirotani, Akane
    Tozuka, Yuichiro
    Fukushima, Taito
    Tezuka, Shun
    Moriya, Satoshi
    Umemoto, Kumiko
    Watanabe, Kazuo
    Sasaki, Mitsuhito
    Hashimoto, Yusuke
    Imaoka, Hiroshi
    Ohno, Izumi
    Mitsunaga, Shuichi
    Yamada, Ikuhiro
    Sasaki, Takashi
    Sasahira, Naoki
    Morimoto, Manabu
    [J]. PANCREAS, 2020, 49 (02) : 187 - 192
  • [5] Multicenter retrospective study of gemcitabine plus nab-paclitaxel for elderly patients with advanced pancreatic cancer
    Ozaka, M.
    Kobayashi, S.
    Ikeda, M.
    Ueno, M.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 270 - 270
  • [6] Maintenance treatment with gemcitabine after gemcitabine plus Nab-paclitaxel in advanced pancreatic cancer
    Kodama, Tomoko
    Nakazawa, Junichi
    Kawahira, Masahiro
    Ymasuji, Akihiro
    Iwashita, Yuji
    Hori, Takeshi
    Kawahira, Machiko
    Arima, Shiho
    Tubouchi, Hirohito
    Ido, Akio
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S484 - S484
  • [7] Predictors of vulnerability to nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Iede, Kiyotsugu
    Yamada, Terumasa
    Tominaga, Shusei
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1453 - S1453
  • [8] Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC)
    Olowokure, Olugbenga
    Torregroza-Sanchez, Maria Patricia
    Bedoya-Apraez, Ivan Dario
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (02) : E16 - E18
  • [9] Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
    Tsujimoto, Akiko
    Sudo, Kentaro
    Nakamura, Kazuyoshi
    Kita, Emiri
    Hara, Ryusuke
    Takayama, Wataru
    Ishii, Hiroshi
    Yamaguchi, Taketo
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [10] Survival of patients with advanced pancreatic cancer is increased by nab-paclitaxel plus gemcitabine
    [J]. Nature Reviews Gastroenterology & Hepatology, 2013, 10 (12) : 695 - 695
12345